Pathway Financial Advisers’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.31M Buy
98,339
+891
+0.9% +$40.7K 1.22% 26
2025
Q4
$4.32M Buy
97,448
+806
+0.8% +$34.7K 1.25% 24
2025
Q3
$4.08M Buy
96,642
+4,927
+5% +$199K 1.19% 26
2025
Q2
$3.36M Buy
91,715
+1,765
+2% +$65.5K 1.09% 30
2025
Q1
$3.43M Buy
89,950
+995
+1% +$37K 1.17% 29
2024
Q4
$3.37M Buy
88,955
+483
+0.5% +$19.3K 1.13% 28
2024
Q3
$3.6M Buy
88,472
+123
+0.1% +$4.65K 1.63% 21
2024
Q2
$3.02M Sell
88,349
-867
-1% -$27.3K 1.08% 28
2024
Q1
$2.83M Buy
89,216
+2,312
+3% +$70.3K 1.02% 32
2023
Q4
$2.66M Buy
86,904
+302
+0.3% +$9.69K 1.01% 30
2023
Q3
$2.87M Buy
+86,602
New +$2.77M 1.19% 27
2023
Q1
$2.33M Buy
84,971
+1,226
+1% +$34.1K 0.94% 32
2022
Q4
$2.34M Buy
+83,745
New +$2.53M 0.95% 32

Other funds holding OHI

Pathway Financial Advisers's OHI Position: Q1 2026 in Review

Pathway Financial Advisers increased its Omega Healthcare (OHI) stake by 0.91% in Q1 2026, buying an estimated $40.7K and bringing the position to 98,339 shares worth $4.31M. The position accounts for 1.22% of the portfolio, ranked #26.

Pathway Financial Advisers first reported a position in OHI in Q4 2022 and has held it in 13 quarters since. The position peaked at $4.32M in Q4 2025. 740 funds tracked by Wall St. Rank hold OHI as of Q1 2026.

  • Pathway Financial Advisers held 98,339 shares of Omega Healthcare worth $4.31M as of Q1 2026.
  • Pathway Financial Advisers bought 891 Omega Healthcare shares in Q1 2026, an estimated $40.7K.
  • Omega Healthcare made up 1.22% of Pathway Financial Advisers's portfolio in Q1 2026, its #26 holding.
  • Pathway Financial Advisers first reported a position in Omega Healthcare in Q4 2022 and has held it in 13 quarters since.
  • Pathway Financial Advisers's Omega Healthcare position peaked at $4.32M in Q4 2025.
  • 740 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.

Based on Pathway Financial Advisers's 13F filing for Q1 2026, filed 23 Apr 2026.